May. 22 at 4:48 PM
🏥
$JNJ 𝗦𝗧𝗥𝗨𝗖𝗧𝗨𝗥𝗘 — 5/22/2026 ✦ 12:47 ET
The defensive bid nobody's talking about. JNJ +1.3% while semis chop.
📊 𝗧𝗵𝗲 𝘀𝗲𝘁𝘂𝗽
▪
$234.67 — reclaiming the 0.702 Fib (
$236.26 overhead)
▪ Swept demand zone at
$219 (0.382), printed a CHoCH — bullish structure shift
▪ Back above the MA at
$227. Range is
$219 (demand) →
$251 (premium/supply)
▪ RSI 45→58, room to run
🧭 𝗧𝗵𝗲 𝗽𝗮𝘁𝗵
▪ Reclaim
$236.26 (0.702) → opens
$240.61 (0.786) →
$245.80 (0.886)
▪ Premium/supply wall at
$245-
$251 is the ceiling. That's where this fades.
▪ Hold
$227 = bull structure intact. Lose it = back to
$219 demand retest.
⚖ 𝗧𝗵𝗲 𝗺𝗮𝗰𝗿𝗼 𝗳𝗿𝗮𝗺𝗲
JNJ trades on litigation + rates, not AI flow. Talc overhang: 67,000+ suits, but the recent verdicts (
$250K Philadelphia) are immaterial vs J&J's
$26B net income. The real swing factor is drug pricing + loss of exclusivity, cushioned by the MedTech pipeline.
🪞 𝗧𝗵𝗲 𝗿𝗲𝗮𝗱
Defensive aristocrat catching a bid while the melt-up looks late-cycle. Falling yields (10Y ~4.55%) help dividend names. When laggards chase and index puts stay bid, low-beta is where cautious money rotates. JNJ green on a red-NVDA day is the tell.
🛡 𝗧𝗵𝗲 𝘁𝗿𝗮𝗱𝗲
Range play: long above
$227 toward
$245 supply, fade the premium zone. Not a momentum name — a mean-reversion / defensive-rotation name. The litigation tail risk caps how much you size.
📜 Watching:
$236 reclaim (continuation) |
$245-251 premium (ceiling) |
$227 (bull line) |
$219 (demand)
NFA. Educational. Paper desk lives.
Process over prediction. Risk-first, always.
#JNJ #wavervanir #volanx #SMC #quant #defensives
